Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV II Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06508749
What this trial is testing

The Tatelo Plus Study

Who this might be right for
HIVHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 41
Testing effectiveness (Phase 2)Study completedNCT00002127
What this trial is testing

A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome

Who this might be right for
HIV InfectionsHIV Wasting Syndrome
Celgene Corporation 75
Testing effectiveness (Phase 2)Study completedNCT03497676
What this trial is testing

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Testing effectiveness (Phase 2)Study completedNCT01504841
What this trial is testing

Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Testing effectiveness (Phase 2)Study completedNCT01008813
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 306
Testing effectiveness (Phase 2)Study completedNCT00225303
What this trial is testing

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 116
Post-approval studies (Phase 4)Study completedNCT03290391
What this trial is testing

Linking Infectious and Narcology Care-Part II

Who this might be right for
HIV InfectionDrug Use
Boston Medical Center 225
Testing effectiveness (Phase 2)Study completedNCT00002210
What this trial is testing

Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies

Who this might be right for
HIV Infections
Pharmacia and Upjohn 24
Testing effectiveness (Phase 2)Study completedNCT00007332
What this trial is testing

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 330
Testing effectiveness (Phase 2)Study completedNCT00917891
What this trial is testing

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
International Partnership for Microbicides, Inc. 280
Testing effectiveness (Phase 2)Study completedNCT00024024
What this trial is testing

BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 59
Not applicableStudy completedNCT01258582
What this trial is testing

Two Approaches to Routine HIV Testing in a Hospital Emergency Department

Who this might be right for
HIV Infections
Massachusetts General Hospital 1,651
Testing effectiveness (Phase 2)Study completedNCT01816490
What this trial is testing

THISTLE - The HIV-HCV Silibinin Trial

Who this might be right for
HIVHepatitis C
University of Zurich 20
Testing effectiveness (Phase 2)UnknownNCT04404049
What this trial is testing

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

Who this might be right for
HIV-1-infection
UBP Greater China (Shanghai) Co., Ltd 39
Early research (Phase 1)Study completedNCT00000755
What this trial is testing

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Testing effectiveness (Phase 2)Looking for participantsNCT04941274
What this trial is testing

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
National Cancer Institute (NCI) 111
Testing effectiveness (Phase 2)WithdrawnNCT00723918
What this trial is testing

Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy

Who this might be right for
HIV-associated NeuropathyPolyneuropathy
Washington University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT00046033
What this trial is testing

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 118
Testing effectiveness (Phase 2)Looking for participantsNCT05470491
What this trial is testing

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Who this might be right for
HIVHematologic Malignancies
National Cancer Institute (NCI) 265
Next Page